To include your compound in the COVID-19 Resource Center, submit it here.

Oxycyte: Phase IIb halted

Oxygen halted a double-blind, placebo-controlled, Israeli and Swiss Phase IIb trial of Oxycyte to treat severe non-penetrating TBI due to difficulties in enrollment. The company said it will consider strategic alternatives for the program and

Read the full 352 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers